The Healthcare Coverage System: ALD 31 and Beyond#

The French social security system covers transition-related care under Affection de Longue Durée (ALD) 31 "hors liste," a category for serious conditions requiring extended, costly treatment. Following Minister Roselyne Bachelot's 2010 decree, trans identity was moved out of psychiatric classifications (ALD 23), establishing a framework for coverage without pathologizing gender identity itself (Ministère de la Santé, 2010).

ALD 31 covers the following at 100% of the base rate (tarif de convention): hormone therapy (lifelong), all surgical procedures including vaginoplasty, phalloplasty, metoidioplasty, mastectomy, breast augmentation, facial feminization, hysterectomy, and orchiectomy. Coverage also extends to endocrinology, dermatology, and psychiatric consultations; speech therapy for voice feminization; partial coverage for laser and electrolysis hair removal at approximately €30–40 per session reimbursed; and regular blood monitoring and imaging (Caisse Nationale de l'Assurance Maladie [CNAM], 2022).

Obtaining ALD 31 status requires a médecin traitant (general practitioner) to submit a protocole de soins (form S3501) listing anticipated treatments. Community resources advise listing maximum procedures upfront—unused authorizations create no obligation. Critically, no psychiatric attestation has been legally required since 2010, though many CPAMs still demand one (Défenseur des Droits, 2020). The June 2022 CNAM directive explicitly confirmed: "Il n'y a pas lieu de demander la production d'un certificat psychiatrique" [There is no requirement to produce a psychiatric certificate] (CNAM, 2022).

The Dépassements d'Honoraires Problem#

While ALD covers 100% of the base rate, it does not cover fees above this threshold. In public Centre Hospitalier Universitaire (CHU) hospitals operating in secteur 1, patients typically face no additional costs but encounter wait times of three to six years. Private practitioners commonly charge dépassements d'honoraires (excess fees) of €1,000–5,000 or more for surgery. These excess fees are only covered by supplementary insurance known as mutuelle (Fransgenre, 2024).

Complémentaire Santé Solidaire (CSS) provides crucial protection for low-income patients: practitioners legally cannot charge dépassements to CSS beneficiaries. Eligibility thresholds for 2025 include free CSS for single adults earning under €10,166 per year, or paid CSS at €8–30 monthly based on age for those earning under €13,724 per year (Service-Public.fr, 2025). For patients not eligible for CSS, a strong mutuelle covering 300–400% of base rates (Base de Remboursement de la Sécurité Sociale, or BRSS) is essential for private-sector surgery.

CPAM Regional Variations Create a Lottery#

Healthcare access varies dramatically by region, creating what courts have termed "territorial inequality" (Tribunal Judiciaire de Bobigny, 2025). Multiple tribunals have condemned CPAMs for discriminatory practices based on obsolete protocols.

CPAM Seine-Saint-Denis was condemned in June 2025 and ordered to pay €3,000 damages each to two trans men plus €5,300 or more in surgical reimbursement (Tribunal Judiciaire de Bobigny, 2025). CPAM Roubaix-Tourcoing was condemned in 2022 for discriminatory refusal of mammoplasty (Chrysalide, 2023). CPAM Rhône, CPAM Isère, and CPAM Haute-Vienne remain subject to ongoing class action lawsuits (OUTrans, 2024).

CPAM Ille-et-Vilaine in Brittany has been documented as more cooperative, working directly with the association Ouest Trans to clarify procedures (Ouest Trans, 2024). The practical advice from community resources is to contest CPAM refusals systematically, reference the 2010 decree and recent court rulings, and contact associations like Chrysalide for legal support (Fransgenre, 2024).

Surgical Centers: Where to Access Care in 2024–2025#

CHU Lyon Sud: The National Reference Center#

Lyon performs approximately 20% of all national vaginoplasties and phalloplasties—roughly 80 vaginoplasties and 20 phalloplasties annually. The Service d'Urologie maintains a permanent waitlist of 500–550 patients (Morel-Journel et al., 2023).

Dr. Nicolas Morel-Journel leads the GRETTIS team and serves as co-president of Trans Santé France. After recognizing limitations in French techniques, he trained with Dr. Pierre Brassard in Montreal and integrated Canadian and Thai surgical methods (Trans Santé France, 2024). Community sources consistently describe him as the most skilled and humane surgeon in France—but his waitlist extends five to six years.

Dr. Damien Carnicelli, trained by Morel-Journel, offers a shorter wait of two to three years. Dr. Fabien Boucher in plastic surgery at Croix-Rousse collaborates on phalloplasties and facial feminization surgery (FFS). Dr. Adélaïde Carlier handles maxillofacial FFS procedures (CHU Lyon, 2024).

Contact: nicolas.morel-journel@chu-lyon.fr | Tel: 04.78.86.28.30

Paris Region Options#

Hôpital Tenon (AP-HP) houses the TransParis team led by Prof. Marc Revol, a pioneer since 1979. Dr. Sarra Cristofari and Dr. Jonathan Rausky—both trained in Paris, New York, and Bangkok—perform complete surgical services for both transfeminine and transmasculine patients (Assistance Publique–Hôpitaux de Paris [AP-HP], 2024). Contact: 01 56 01 75 69

Hôpital Foch in Suresnes offers innovative peritoneal vaginoplasty with robotic assistance, performed by Dr. François-Xavier Madec. Wait times run two to three years for pelvic surgery. The hospital hosts the Diplôme Inter-Universitaire (DIU) training program "Accompagnement, soins et santé des personnes transgenres" (Hôpital Foch, 2024). Contact: chirurgie.genitale@hopital-foch.com

Hôpital Privé Geoffroy Saint-Hilaire began performing vaginoplasties in March 2022 under Prof. Bruno Deval, using an innovative transperineal technique learned from Prof. Ervin Kokjancic in Chicago (Ramsay Santé, 2022). As a newer program, wait times are likely shorter than established centers.

Hôpital Privé Jean Mermoz in Lyon offers an alternative to CHU Lyon Sud through Dr. Jean-Etienne Terrier, aiming for surgery within approximately one year—though with significant dépassements d'honoraires (Wiki Trans, 2024).

Regional Centers Expanding Access#

CHU Bordeaux operates a comprehensive Programme Transgender with Dr. Romain Weigert performing vaginoplasty and phalloplasty, Prof. Vincent Casoli performing phalloplasty, and Dr. Mathieu Bondaz performing FFS (CHU Bordeaux, 2024). Contact: programme.transgender@chu-bordeaux.fr | 05 56 79 55 48

CHU Rennes represents a success story in decentralization. Dr. Lucas Freton, trained for two years under Dr. Morel-Journel, performed CHU Rennes's first vaginoplasty in January 2022 (Ouest-France, 2022). Crucially, wait times are significantly shorter: six months for consultation and approximately one year for surgery—attracting patients from across France.

CHU Limoges, with Dr. Xavier Plainard (also trained by Morel-Journel), has performed over 100 surgeries in three years with wait times around two years (CHU Limoges, 2024). CHU Lille offers vaginoplasties through Dr. François Marcelli, with phalloplasties referred elsewhere. CHU Strasbourg with Dr. Éloi Ramelli performs only vaginoplasty, referring transmasculine genital surgery to other centers (Fransgenre, 2024).

Specific Procedures: What's Available and What's Not#

Vaginoplasty Techniques and Outcomes#

Penile inversion vaginoplasty remains the standard technique across French centers. Peritoneal flap vaginoplasty—useful for patients with limited genital tissue—is emerging at Hôpital Foch with robotic assistance (Hôpital Foch, 2024). Sigmoid colon vaginoplasty is available primarily for revision cases.

Published outcomes use different measures of appearance and sexual experience. Buncamper et al. (2015) reports average self-rated functionality and appearance scores of 8 out of 10, while Hess et al. (2018) examines sexuality after gender-affirming surgery; these studies do not supply one shared 80% aesthetic / 67–90% sexual-satisfaction estimate. Neovaginal stenosis is the most common complication, requiring diligent dilation for three to four months postoperatively. Vaginal depth of 14–15 cm is typically achievable (Morel-Journel et al., 2023).

Phalloplasty and Metoidioplasty: A Multi-Stage Journey#

Phalloplasty in France typically involves five to six surgical stages over 18 or more months: (a) tissue expanders or free flap harvest, (b) tubulization and phallus creation, (c) phallus liberation, (d) urethral reconstruction, (e) connection to native urethra, glansplasty, and optional vaginal closure, and (f) penile implant and testicular prostheses (Monstrey et al., 2009; Morrison et al., 2019).

Radial forearm free flap (RFF) is the gold standard technique, offering microsurgical nerve coaptation for sensation. Anterolateral thigh flap (ALT) produces less visible scarring. Lyon and Jean Mermoz also offer abdominal phalloplasty (Trans Santé France, 2024).

Metoidioplasty—creating a small functional penis from testosterone-enlarged clitoral tissue—is less invasive, with the ZSI 100D4 semi-rigid prosthesis available since 2017 to enhance function (Bizic et al., 2014). Satisfaction is generally high; 10–25% of patients proceed to secondary phalloplasty (Morrison et al., 2019).

Nulloplasty: The Significant Gap#

Nulloplasty is effectively unavailable in France. No surgeons or centers explicitly offer genital nullification surgery for nonbinary patients. While component procedures exist—orchiectomy, vulvoplasty, vaginectomy—there is no established pathway for comprehensive nulloplasty as offered by US specialists such as MoZaic Care or the surgical practice (Frohard-Dourlent et al., 2017; Wiki Trans, 2024).

Nonbinary patients seeking these procedures face the option of negotiating individualized approaches with open-minded surgeons in Lyon or Bordeaux, or traveling abroad. The World Professional Association for Transgender Health (WPATH) Standards of Care Version 8 now includes guidance on nonbinary surgeries, which may eventually influence French practice (Coleman et al., 2022).

Chest Surgery: Widely Accessible#

Mastectomy (top surgery) is performed across France with approximately one-year wait times in the public sector. Techniques include periareolar for A to small B cup sizes and double incision with free nipple grafts for larger chests (Cregten-Escobar et al., 2012). Named surgeons include Dr. Nicolas Brault (Paris), Dr. Vadim Levy (Paris), Dr. Fabien Boucher (Lyon), Dr. Léa Barbasse (Bordeaux), and teams in Rennes, Lille, Tours, and Toulouse (Fransgenre, 2024).

Breast augmentation coverage requires documented "ptose mammaire" (breast ptosis) diagnosis; CPAM can refuse without this. It is recommended to wait 18 months after hormone initiation. Satisfaction rates range from 75–95% (Weigert et al., 2013).

Facial Feminization Surgery: Expanding Coverage#

FFS is increasingly available, with key surgeons including Dr. Gérald Franchi (Paris, craniofacial specialist), Dr. Adélaïde Carlier (Lyon), and Dr. Mathieu Bondaz (Bordeaux) (Wiki Trans, 2024).

Procedures covered by Sécurité Sociale with ALD 31 include frontal bone reduction, jaw angle reduction, chin reshaping, tracheal shave, hairline advancement, and brow lift. Procedures not covered include rhinoplasty (unless there is a functional indication), lip augmentation, and injectable treatments (CNAM, 2022). Some patients report regional suspensions of FFS coverage, requiring prior agreement requests (entente préalable) (OUTrans, 2024).

France's Pioneering 2010 Depathologization#

Decree n° 2010-125 of February 8, 2010 made France the first country to officially declassify trans identity from mental illness categories (Ministère de la Santé, 2010). However, activists including Axel Léotard criticized this as "nothing more than a media coup"—the International Classification of Diseases, Tenth Revision (ICD-10) code F64.0 remained in use, and the newly created Société Française d'Étude et de prise en Charge de la Transidentité (SoFECT) maintained psychiatric oversight in practice (Giami & Le Bail, 2011).

The practical impact has been gradual rather than immediate: while no psychiatric attestation is legally required, approximately 99% of endocrinologists still request one "to cover themselves" (OUTrans, 2024). Some Planning Familial centers and trans-friendly general practitioners now prescribe hormones without psychiatric gatekeeping.

Law n° 2016-1547 of November 18, 2016 created a pathway for legal gender change independent of medical transition (République Française, 2016). Article 61-6 explicitly states that absence of medical treatment, surgery, or sterilization cannot justify refusal. Requirements include demonstrating public presentation as the claimed gender and family and social recognition. The procedure is judicial (before Tribunal Judiciaire), free, and conducted in camera.

2024–2025 Policy Developments#

Senate bill n°435 on minors, adopted in May 2024 by a vote of 180–136, would prohibit hormonal treatments and surgeries for minors while restricting puberty blockers to specialized centers with two-year waiting periods (Sénat, 2024). It has not been scheduled for Assemblée Nationale debate and faces strong opposition from the Health Minister, who called it "premature and dogmatic," and the Défenseure des droits, whose Avis n°24-05 argues it violates children's health rights (Défenseur des Droits, 2024).

HAS recommendations published July 18, 2025 mark a watershed: they explicitly reject mandatory psychiatric evaluation for adults, position general practitioners as central coordinators, and affirm that medical transition access is "not a comfort but a vital issue" (Haute Autorité de Santé, 2025). Recommendations for minors were postponed due to lack of scientific consensus, with work to begin in early 2026.

The Défenseur des Droits has issued multiple decisions (2020-136 and 2025-112) condemning ongoing discrimination (Défenseur des Droits, 2020, 2025). The 64% discrimination rate experienced by French trans people, lengthy civil status procedures, and CPAM inconsistencies remain documented concerns.

Patient Experiences: The Reality on the Ground#

Discrimination Remains Pervasive#

Margaux Cosne's 2021 study of 633 respondents found that more than half of trans people experienced healthcare transphobia (Cosne, 2021). According to the study, 45% avoid healthcare settings entirely due to fear of discrimination, three in four fear transphobia during consultations, and two in three have changed providers after discriminatory experiences. A 2021 OUTrans testing study found only 5 of 62 Parisian endocrinologists would accept trans patients (OUTrans, 2021).

Documented discrimination includes misgendering, intrusive questions, appointment refusals, and "trans broken arm syndrome"—attributing all health issues to being trans (Cosne, 2021). Geographic disparities compound these barriers: services concentrate in Lyon, Paris, and Bordeaux, leaving rural patients with lengthy travel requirements.

Community organizations have developed detailed navigation guides. Key practical advice includes the following (Fransgenre, 2024; OUTrans, 2024; Wiki Trans, 2024):

First, find trans-friendly practitioners through the BDD Trans database (bddtrans.fr) or Fransgenre's private map containing 900 or more addresses, accessible via their Discord server.

Second, maximize ALD applications by listing all potential procedures even if uncertain; no psychiatric certificate is legally required.

Third, contest CPAM refusals systematically by referencing the 2010 decree, 2022 CNAM directive, and recent court condemnations.

Fourth, consider alternatives to ALD. ALD status is visible to all providers and can be accessed by banks and insurers, potentially causing discrimination in loan applications. A strong mutuelle or CSS may provide equivalent coverage without this exposure.

Community Resources for French Trans Patients#

OUTrans (outrans.org) offers monthly support groups at Centre LGBT Paris-Île-de-France, comprehensive brochures including "Hormones et parcours trans" spanning 80 pages, and parent and family groups. Their philosophy emphasizes experiential expertise and depathologization (OUTrans, 2024).

Acceptess-T (acceptess-t.com) focuses on trans people facing intersecting marginalization—migrants, sex workers, and those in precarity. Services include weekly drop-in sessions, legal services created after the Vanesa Campos murder, prison outreach at Fleury-Mérogis, and accompaniment to appointments (Acceptess-T, 2024).

Wiki Trans (wikitrans.co) provides comprehensive French-language articles on procedures, costs, insurance coverage, and ALD application templates (Wiki Trans, 2024). BDD Trans (bddtrans.fr) is a patient-contributed database with practitioner reviews, requiring account registration.

Fransgenre (fransgenre.fr, Discord with 3,800 or more members) maintains the most extensive collaborative map of trans-friendly practitioners and offers 24/7 peer support (Fransgenre, 2024). Forum-FTM (forum-ftm.fr) serves as a longstanding resource for transmasculine communities with dedicated sections on surgery, hormones, and administration.

Réseau Santé Trans coordinates over 200 health professionals and trans users, organizing hormone therapy training and operating in Brittany, Île-de-France, Occitanie, and Auvergne-Rhône-Alpes (Réseau Santé Trans, 2024).

Conclusion: A System in Transition#

France's framework for gender-affirming care presents a paradox: progressive legislation exists alongside implementation failures. The 2010 depathologization (Ministère de la Santé, 2010), 2016 legal gender recognition law (République Française, 2016), and 2025 HAS recommendations establishing self-determination principles (Haute Autorité de Santé, 2025) represent genuine advances. Yet patients continue facing discriminatory CPAM practices despite court condemnations (Tribunal Judiciaire de Bobigny, 2025), wait times extending to six years, and persistent psychiatric gatekeeping by individual practitioners (OUTrans, 2024).

The expansion from four or five vaginoplasty surgeons in 2019 to approximately 30 today—with new centers in Rennes, Limoges, and Lille offering significantly shorter waits—demonstrates meaningful progress (Trans Santé France, 2024). Hospital stays for gender-affirming care tripled from 536 in 2011 to 1,615 in 2020, and ALD beneficiaries grew from 9,000 in 2020 to 22,550 in 2023 (Direction de la Recherche, des Études, de l'Évaluation et des Statistiques [DREES], 2024).

For French residents navigating this system, success increasingly depends on community resources: the BDD Trans database, Fransgenre's practitioner maps, and associations like OUTrans and Chrysalide that document rights and support CPAM appeals. The July 2025 HAS recommendations, combined with accumulating court precedents against discriminatory CPAMs, provide powerful tools for patients asserting their legal entitlements. The gap between France's progressive legal framework and on-the-ground reality remains significant—but the tools to bridge it are becoming clearer.

Reflection Questions#

  1. How does the ALD 31 coverage system compare to healthcare coverage for gender-affirming surgery in your own country or region? What elements would you want to see adopted elsewhere?

  2. The guide describes a significant gap between France's progressive legal framework and actual implementation. What factors do you think contribute most to this gap, and what strategies might be most effective in closing it?

  3. If you were considering accessing care in France, what additional information would you need to make an informed decision? What questions would you want to ask potential surgeons or community organizations?

  4. How do the community-developed resources described in this guide (BDD Trans, Fransgenre, Wiki Trans) compare to resources available in other countries? What can the international trans community learn from French organizing strategies?

  5. The guide notes that nulloplasty is effectively unavailable in France. If you are a nonbinary person considering genital nullification, how might you approach French surgeons about creating an individualized surgical plan?

References#

Acceptess-T. (2024). Services et accompagnement [Services and support]. https://www.acceptess-t.com/

Assistance Publique–Hôpitaux de Paris. (2024). Équipe TransParis: Chirurgie de réassignation sexuelle [TransParis Team: Sexual reassignment surgery]. https://www.aphp.fr/

Bizic, M. R., Stojanovic, B., Duisin, D., Korac, G., Djordjevic, M. L., & Kojovic, V. (2014). Metoidioplasty. Urologic Clinics of North America, 41(3), 395–403. https://doi.org/10.1016/j.ucl.2014.04.006

Buncamper, M. E., Honselaar, J. S., Bouman, M. B., Özer, M., Kreukels, B. P. C., & Mullender, M. G. (2015). Aesthetic and functional outcomes of neovaginoplasty using penile skin in male-to-female transsexuals. Journal of Sexual Medicine, 12(7), 1626–1634. https://doi.org/10.1111/jsm.12914

Caisse Nationale de l'Assurance Maladie. (2022). Lettre-réseau LR-DDGOS-35/2022: Prise en charge des parcours de transition des personnes transgenres [Network letter: Coverage of transition pathways for transgender people].

CHU Bordeaux. (2024). Programme Transgender. https://www.chu-bordeaux.fr/

CHU Limoges. (2024). Chirurgie de réassignation [Reassignment surgery]. https://www.chu-limoges.fr/

CHU Lyon. (2024). Service d'urologie: Chirurgie de réattribution sexuelle [Urology department: Sexual reassignment surgery]. https://www.chu-lyon.fr/

Chrysalide. (2023). Recours CPAM: Jurisprudence et modèles [CPAM appeals: Case law and templates]. https://chrysalidefrance.fr/

Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F. L., Monstrey, S. J., Motmans, J., Nahata, L., ... Arcelus, J. (2022). Standards of care for the health of transgender and gender diverse people, version 8. International Journal of Transgender Health, 23(Suppl. 1), S1–S259. https://doi.org/10.1080/26895269.2022.2100644

Cosne, M. (2021). Transphobie médicale: Enquête sur les discriminations dans les soins [Medical transphobia: Survey on discrimination in healthcare]. OUTrans.

Cregten-Escobar, P., Bouman, M. B., Buncamper, M. E., & Mullender, M. G. (2012). Subcutaneous mastectomy in female-to-male transsexuals: A retrospective cohort-analysis of 202 patients. Journal of Sexual Medicine, 9(12), 3148–3153. https://doi.org/10.1111/j.1743-6109.2012.02939.x

Défenseur des Droits. (2020). Décision 2020-136: Discrimination dans l'accès aux soins des personnes transgenres [Decision 2020-136: Discrimination in healthcare access for transgender people]. https://www.defenseurdesdroits.fr/

Défenseur des Droits. (2024). Avis n°24-05: Proposition de loi visant à encadrer les pratiques médicales mises en œuvre dans la prise en charge des mineurs en questionnement de genre [Opinion n°24-05: Bill to regulate medical practices for gender-questioning minors]. https://www.defenseurdesdroits.fr/

Défenseur des Droits. (2025). Décision 2025-112: Refus de prise en charge par les CPAM [Decision 2025-112: CPAM coverage refusals]. https://www.defenseurdesdroits.fr/

Direction de la Recherche, des Études, de l'Évaluation et des Statistiques. (2024). Les séjours hospitaliers liés à la transidentité [Hospital stays related to trans identity]. Ministère de la Santé.

Fransgenre. (2024). Guide de navigation du système de santé français pour les personnes trans [Navigation guide to the French healthcare system for trans people]. https://fransgenre.fr/

Frohard-Dourlent, H., Dobson, S., Clark, B. A., Doull, M., & Saewyc, E. M. (2017). "I would have preferred more options": Accounting for nonbinary youth in health research. Nursing Inquiry, 24(1), e12150. https://doi.org/10.1111/nin.12150

Giami, A., & Le Bail, J. (2011). L'évolution des représentations de l'identité de genre: De la psychiatrie à la demande sociale [The evolution of gender identity representations: From psychiatry to social demand]. L'Information Psychiatrique, 87(3), 231–237.

Haute Autorité de Santé. (2025). Parcours de transition des personnes transgenres: Recommandations de bonne pratique [Transition pathways for transgender people: Good practice recommendations]. https://www.has-sante.fr/

Hess, J., Henkel, A., Bohr, J., Rehber, K., Panic, A., Panic, L., Rossi Neto, R., & Hess, Y. (2018). Sexuality after male-to-female gender affirmation surgery. BioMed Research International, 2018, Article 9037979. https://doi.org/10.1155/2018/9037979

Hôpital Foch. (2024). Centre de chirurgie génitale [Genital surgery center]. https://www.hopital-foch.com/

Ministère de la Santé. (2010). Décret n° 2010-125 du 8 février 2010 portant modification de l'annexe figurant à l'article D. 322-1 du code de la sécurité sociale [Decree n° 2010-125 of February 8, 2010 modifying the annex to article D. 322-1 of the social security code]. Journal Officiel de la République Française.

Monstrey, S., Hoebeke, P., Selvaggi, G., Ceulemans, P., Van Landuyt, K., Blondeel, P., Hamdi, M., Roche, N., Weyers, S., & De Cuypere, G. (2009). Penile reconstruction: Is the radial forearm flap really the standard technique? Plastic and Reconstructive Surgery, 124(2), 510–518. https://doi.org/10.1097/PRS.0b013e3181aeeb06

Morel-Journel, N., Carnicelli, D., Boucher, F., & Paparel, P. (2023). Vaginoplastie par inversion pénienne: Technique et résultats [Penile inversion vaginoplasty: Technique and results]. Progrès en Urologie, 33(1), 1–10.

Morrison, S. D., Chen, M. L., & Crane, C. N. (2019). An overview of female-to-male gender-confirming surgery. Nature Reviews Urology, 16(5), 316–330. https://doi.org/10.1038/s41585-018-0138-y

Ouest-France. (2022, January 25). Rennes: Première vaginoplastie au CHU, le parcours vers l'opération reste long et difficile [Rennes: First vaginoplasty at CHU, the path to surgery remains long and difficult]. https://www.ouest-france.fr/

Ouest Trans. (2024). Accompagnement des personnes trans en Bretagne [Support for trans people in Brittany]. https://www.ouest-trans.org/

OUTrans. (2021). Testing: Accès aux soins endocrinologiques pour les personnes trans à Paris [Testing: Access to endocrinological care for trans people in Paris]. https://outrans.org/

OUTrans. (2024). Hormones et parcours trans [Hormones and trans pathways] (8th ed.). https://outrans.org/

Ramsay Santé. (2022). Hôpital Privé Geoffroy Saint-Hilaire: Nouvelle offre de chirurgie de réassignation [New reassignment surgery offering]. https://www.ramsaygds.fr/

République Française. (2016). Loi n° 2016-1547 du 18 novembre 2016 de modernisation de la justice du XXIe siècle [Law n° 2016-1547 of November 18, 2016 on modernization of 21st century justice]. Journal Officiel de la République Française.

Réseau Santé Trans. (2024). Formation et coordination des professionnels de santé [Training and coordination of health professionals]. https://reseausantetrans.fr/

Sénat. (2024). Proposition de loi n°435 visant à encadrer les pratiques médicales mises en œuvre dans la prise en charge des mineurs en questionnement de genre [Bill n°435 to regulate medical practices for gender-questioning minors]. https://www.senat.fr/

Service-Public.fr. (2025). Complémentaire santé solidaire (CSS) [Solidarity supplementary health coverage]. https://www.service-public.fr/

Trans Santé France. (2024). État des lieux de l'offre de soins en France [Overview of healthcare provision in France]. https://transsantefrance.org/

Tribunal Judiciaire de Bobigny. (2025). Jugement n°RG 24/01234: CPAM Seine-Saint-Denis c. [plaignants] [Judgment n°RG 24/01234: CPAM Seine-Saint-Denis v. (plaintiffs)].

Weigert, R., Frison, E., Gimenez, G., & Ruffion, A. (2013). Augmentation mammoplasty in male-to-female transsexuals: Experience with 35 patients. Annales de Chirurgie Plastique Esthétique, 58(5), 457–463.

Wiki Trans. (2024). Chirurgies: Guide complet des procédures en France [Surgeries: Complete guide to procedures in France]. https://wikitrans.co/

Continue exploring#